Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 6, Issue 3, 2024

Clinical study on treatment of chronic heart failure with Chinese and Western medicine

Download as PDF

DOI: 10.23977/medcm.2024.060315 | Downloads: 16 | Views: 785

Author(s)

Chen Junlin 1, Fan Xiufeng 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Affiliated Hospital of Integrated Traditional and Western Medicine of Shaanxi University of Chinese Medicine, Xi'an, 710000, China

Corresponding Author

Fan Xiufeng

ABSTRACT

Chronic heart failure is a common disease in the middle and old age, its morbidity and mortality increase year by year, and its high rate of re-hospitalization seriously affects the quality of life of patients. In recent years, the understanding and treatment of chronic heart failure in Chinese medicine and Western medicine have been deepening, and they have been trying to apply new treatment methods, and have achieved good clinical effect. Traditional Chinese medicine improves patients' symptoms and delays the progression of the disease through syndrome differentiation and classification, while Western medicine extends patients' life expectancy by adopting a variety of treatments for the disease. This article summarizes the latest research progress of Chinese and Western medicine treatment of chronic heart failure.

KEYWORDS

Chronic heart failure; Cardiovascular system diseases; Integration of traditional Chinese and western medicine

CITE THIS PAPER

Chen Junlin, Fan Xiufeng, Clinical study on treatment of chronic heart failure with Chinese and Western medicine. MEDS Chinese Medicine (2024) Vol. 6: 106-111. DOI: http://dx.doi.org/10.23977/medcm.2024.060315.

REFERENCES

[1] Dagenais Gilles R, Leong Darryl P, Rangarajan Sumathy, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE):a prospective cohort study [J].Lancet, 2020, 395:785-794.
[2] Qu Zhengyan, Zhang Limin, Shuai Zhongtai. Jiaweiyanghe Decoction treating 20 cases of heart failure [J]. Guangming Chinese Medicine, 2016, 31(19):28222825. (in Chinese)
[3] Yao Shengqing. Clinical effect analysis of ephehuang Fuzi Xixin Decoction and Heyang Decoction in the treatment of chronic arrhythmia [J]. Henan Medical Research, 2015, 24(9):126-127.
[4] Chen Dalei, Si Changrong, Wu Chunping. Clinical observation on 30 cases of sinus bradycardia caused by Yang deficiency and cold coagulation with Yanghe Decoction [J]. Heilongjiang Chinese Medicine, 2015, 44(4):12-13.
[5] Xu Xiangling, Li Menglei, Li Boyang, et al. Systematic evaluation and meta-analysis of the efficacy of cinnamon for warming Yang in treating heart failure [J]. Yunnan Journal of Traditional Chinese Medicine, 2022, 43(3):28-35.
[6] Li Yihua, Chen Qi, Kang Liang, et al. Study on the molecular mechanism of ginseng, salvia miltiorrhiza and draba seed in the treatment of chronic heart failure based on network pharmacology and molecular docking technology [J]. Journal of Cardio-Cerebrovascular Diseases of Integrated Chinese and Western Medicine, 2022, 20(21):3855-3863.
[7] Zhang Yanping, Wang Jiawei, Wang Chunmei, et al. Effect of sacubactril and valsartan combined with Qishenyiqi dropping pills in the treatment of chronic heart failure and its influence on myocardial remodeling and vascular endothelial function [J]. Clinical Misdiagnosis and treatment, 2012, 35 (4): 26-30.
[8] Li Xinli, Zhang Jian, Huang Jun, et al. A multicenter, randomized, double-blind, placebo-controlled clinical evaluation of Qiliqiangxin capsule in the treatment of chronic heart failure [C]. Proceedings of the 13th International Congress of Collaterals, 2017:41-42.
[9] Shi Jun, Wang Wang, Zhao Huihui, et al. Analysis of modern clinical medication of chronic heart failure in Chinese medicine in recent 20 years [J]. Journal of Beijing University of Chinese Medicine, 2019, 43 (10): 841-848.
[10] Ruan Jing, Wang Jing. Effects of Danshen Chuanxiustrazine injection combined with recombinant human brain natriuretic peptide on the expression of miR-423-5p and miR-451a in peripheral blood of patients with chronic heart failure [J] Cardio-cerebral vascular disease combined with traditional Chinese and Western medicine. 2022, 20(6): 1047-1051.
[11] Ling Jing, Xu Liang. Clinical effect of Shenmai injection combined with Bisoprolol in treatment of chronic heart failure in elderly patients [J]. Journal of Clinical Medicine Engineering, 2012, 29 (3): 365-366.
[12] Armstrong Paul W, Pieske Burkert, Anstrom Kevin J, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction[J]. N Engl J Med, 2020, 382:1883-1893.
[13] McMurray John J V, Solomon Scott D, Inzucchi Silvio E, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction[J]. N Engl J Med, 2019, 381:1995-2008. 
[14] Packer Milton, Anker Stefan D, Butler Javed, et al.Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure[J].N Engl J Med, 2020, 383:1413-1424. 
[15] Zannad Faiez, Ferreira João Pedro, Pocock Stuart J, et al.SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials[J]. Lancet, 2020, 396:819-829. 
[16] Petrie Mark C, Verma Subodh, Docherty Kieran F, et al.Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes[J].JAMA, 2020, 323:1353-1368. 
[17] Anker Stefan D, Butler Javed, Filippatos Gerasimos, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J]. N Engl J Med, 2021, 85:1451-1461.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 8626
Visits: 502470

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.